Search

Now showing items 1-10 of 14

Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis

Alvarez-Gonzalez, C; Adams, A; Mathews, J; Turner, BP; Giovannoni, G; Baker, D; Schmierer, K (2017-07)

Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?

Mao, Z; Álvarez-Gonzalez, C; De Trane, S; Yildiz, O; Albor, C; Doctor, G; Soon, D; Pepper, G; Turner, BP; Marta, M;... (2018-04)

Background: A considerable number of people with multiple sclerosis (pwMS) live in low- and middle-income countries (LMIC), where lack of resource adversely affects access to effective disease-modifying treatment. Objective: ...

Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies.

Mao, Z; Álvarez-González, C; Allen-Philbey, K; De Trane, S; Yildiz, O; Campion, T; Adams, A; Turner, BP; Marta, M; Gnanapavan, S;... (Elsevier/Science Direct, 2018-11-02)

BACKGROUND: Whilst there is a broad selection of drugs licensed as disease modifying treatments (DMTs) for people with relapsing multiple sclerosis (pwRMS), access to DMTs remains restricted, particularly for people with ...

Search

Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis

Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?

Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies.

TREATING MULTIPLE SCLEROSIS WITH CLADRIBINE

Severe skin reactions associated with cladribine in people with multiple sclerosis

Cladribine Personalised Dosing to Treat Active Multiple Sclerosis - Follow-up in 250 patients

Cladribine personalised dosing in people with MS (n > 200) - four years experience in clinical care.

CLADRIPLAS: Does cladribine Target CNS plasma cells and reduce neuro-axonal damage in people with MS?

Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients

Treating multiple sclerosis with generic cladribine

Search

Filters

Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis

Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?

Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies.

TREATING MULTIPLE SCLEROSIS WITH CLADRIBINE

Severe skin reactions associated with cladribine in people with multiple sclerosis

Cladribine Personalised Dosing to Treat Active Multiple Sclerosis - Follow-up in 250 patients

Cladribine personalised dosing in people with MS (n > 200) - four years experience in clinical care.

CLADRIPLAS: Does cladribine Target CNS plasma cells and reduce neuro-axonal damage in people with MS?

Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients

Treating multiple sclerosis with generic cladribine